September 2014 FDA Recall Drug by Zydus Pharmaceuticals Usa Inc
D-0289-2015 - Presence of Foreign Capsules/Tablets

This Class III drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on September 24, 2014 for the product Drug. The FDA reported the reason for recall as presence of foreign capsules/tablets. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0289-2015

Reason for Recall
Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.
Initiated
09-24-2014
Reported
12-10-2014
Quantity
63,648 Bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Zydus Pharmaceuticals USA Inc
US Nationwide including Puerto Rico
BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01

Batch or Lot Expiration Information

Lot# : MM8555, Expiry: 09/14
Lot# : MM6604, Expiry: 09/14
Lot# : MM8551, Expiry: 09/14
Lot# : MM8552, Expiry: 09/14
Lot# : MM8553, Expiry: 09/14
Lot# : MM8554, Expiry: 09/14.